Prime Editing Unlocks a Universal Strategy for Restoring Lost Proteins
November 22, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Doralese
Synonyms :
indoramin
Class :
Adrenergic alpha-1 antagonist and antihypertensive
Brand Name :
Doralese
Synonyms :
indoramin
Class :
Adrenergic alpha-1 antagonist and antihypertensive
Dosage Forms & Strengths
Tablet, Oral:
20 mg
25 mg
25
mg
Tablet
Oral
twice a day
20
mg
Tablet
Oral
twice a day
No safe and efficacious dosing available
Refer to adult dosing
may increase the hypotensive effect of anti-hypertensive agents
may increase the hypotensive effect of anti-hypertensive agents
may decrease the diagnostic effect when combined with benzylpenicilloyl polylysine
may have an increased hypertensive effect when combined with alpha1-blockers
may have an increased bradycardic effect when combined with ceritinib
may have an increased bradycardic effect when combined with fingolimod
may have an increased bradycardic effect when combined with ponesimod
may have an increased bradycardic effect when combined with siponimod
may enhance the hypotensive effect of phosphodiesterase 5 Inhibitors
may increase the hypotensive effect of anti-hypertensive agents
may increase the serum concentration of each other when it is combined
may increase the serum concentration of each other when it is combined
may increase the serum concentration of each other when it is combined
may increase the serum concentration of each other when it is combined
may increase the action of CNS depressants inducing CNS depression
may increase the action of CNS depressants inducing CNS depression
may increase the action of CNS depressants inducing CNS depression
may increase the action of CNS depressants inducing CNS depression
may increase the action of CNS depressants inducing CNS depression
betony along with antihypertensive drugs can lower blood pressure abruptly which is contraindicated
bloodroot along with antihypertensive medications will result in amplified hypotensive effect
may enhance the antihypertensive effect of other alpha1-Blockers
bunazosin (Not available in the United States)
may enhance the antihypertensive effect of other alpha1-Blockers
may enhance the antihypertensive effect of other alpha1-Blockers
may enhance the antihypertensive effect of other alpha1-Blockers
may enhance the antihypertensive effect of other alpha1-Blockers
may have an increased hypotensive effect when combined with calcium channel blockers
may have an increased hypotensive effect when combined with calcium channel blockers
may have an increased hypotensive effect when combined with calcium channel blockers
may have an increased hypotensive effect when combined with calcium channel blockers
may have an increased hypotensive effect when combined with calcium channel blockers
may enhance the antihypertensive effect of other alpha1-Blockers
may enhance the antihypertensive effect of other alpha1-Blockers
may enhance the antihypertensive effect of other alpha1-Blockers
may enhance the antihypertensive effect of other alpha1-Blockers
may enhance the antihypertensive effect of other alpha1-Blockers
it decreases the effect of hypotension on blood-lowering agents
may increase the hypotensive effect of anti-hypertensive agents
may increase the hypertensive effect of Monoamine Oxidase inhibitors
may decrease the therapeutic effect when combined with etofylline
they increase the efficacy of hypotension-associated agents
may increase the hypertensive effect when combined with androgens
it reduces the efficacy of blood pressure-lowering agents
may have an increased vasoconstricting effect when combined with alpha1-agonists
may have an increased vasoconstricting effect when combined with alpha1-agonists
may have an increased vasoconstricting effect when combined with alpha1-agonists
may have an increased vasoconstricting effect when combined with alpha1-agonists
may have an increased vasoconstricting effect when combined with alpha1-agonists
may have an increased hypertensive effect when combined with alpha1-agonists
may have an increased hypertensive effect when combined with alpha1-agonists
may have an increased hypertensive effect when combined with alpha1-agonists
may have an increased hypertensive effect when combined with alpha1-agonists
may have an increased hypertensive effect when combined with alpha1-agonists
may enhance the hypotensive effect of blood Pressure Lowering Agents
may enhance the hypotensive effect of blood Pressure Lowering Agents
may enhance the hypotensive effect of blood Pressure Lowering Agents
may enhance the hypotensive effect of blood Pressure Lowering Agents
may enhance the hypotensive effect of blood Pressure Lowering Agents
may increase the hypotensive effect
may increase the hypotensive effect
may increase the hypotensive effect
may increase the hypotensive effect
may increase the hypotensive effect
may decrease the vasoconstriction effects
may enhance the effect of antipsychotic agents
may enhance the effect of antipsychotic agents
may enhance the effect of antipsychotic agents
may enhance the effect of antipsychotic agents
may enhance the effect of antipsychotic agents
may enhance the effect of antipsychotic agents
may enhance the effect of antipsychotic agents
may enhance the effect of antipsychotic agents
may enhance the effect of antipsychotic agents
may enhance the effect of antipsychotic agents
may enhance the effect of antipsychotic agents
may enhance the effect of antipsychotic agents
may enhance the effect of antipsychotic agents
may enhance the effect of antipsychotic agents
may enhance the effect of antipsychotic agents
may enhance the effect of antipsychotic agents
may enhance the effect of antipsychotic agents
may enhance the effect of antipsychotic agents
may enhance the effect of antipsychotic agents
may enhance the effect of antipsychotic agents
may enhance the effect of antipsychotic agents
may enhance the effect of antipsychotic agents
may enhance the effect of antipsychotic agents
may enhance the hypotensive effect of antipsychotic agents
may enhance the hypotensive effect of antipsychotic agents
may enhance the hypotensive effect of antipsychotic agents
may enhance the hypotensive effect of antipsychotic agents
may enhance the hypotensive effect of antipsychotic agents
may enhance the hypotensive effect of antipsychotic agents
may enhance the hypotensive effect
may enhance the hypotensive effect
may enhance the hypotensive effect
may enhance the hypotensive effect
may enhance the hypotensive effect
may have an increased hypotensive effect when combined with anti-hypertensive agents
may have an increased hypotensive effect when combined with anti-hypertensive agents
may have an increased hypotensive effect when combined with anti-hypertensive agents
may have an increased hypotensive effect when combined with anti-hypertensive agents
may have an increased hypotensive effect when combined with anti-hypertensive agents
may have an increased hypotensive effect when combined with antipsychotic agents
may have an increased hypotensive effect when combined with antipsychotic agents
may have an increased hypotensive effect when combined with antipsychotic agents
may have an increased hypotensive effect when combined with antipsychotic agents
may have an increased hypotensive effect when combined with antipsychotic agents
relugolix/estradiol/norethindrone
may enhance the hypertensive effect of Androgens
relugolix/estradiol/norethindrone
may enhance the hypertensive effect of Androgens
may enhance the hypertensive effect of Androgens
may enhance the hypertensive effect of Androgens
may enhance the hypertensive effect of Androgens
may have an increased hypotensive effect when combined with antipsychotic agents
may have an increased hypotensive effect when combined with antipsychotic agents
may have an increased hypotensive effect when combined with antipsychotic agents
may have an increased hypotensive effect when combined with antipsychotic agents
may have an increased hypotensive effect when combined with antipsychotic agents
may have an increased hypotensive effect when combined with hypotension-associated agents
may have an increased hypotensive effect when combined with hypotension-associated agents
may have an increased hypotensive effect when combined with antihypertensive agents
may have an increased hypotensive effect when combined with antihypertensive agents
may have an increased hypotensive effect when combined with antihypertensive agents
It may increase the hypotensive effect when combined with Antihypertensive Agents
It may increase the hypotensive effect when combined with Antihypertensive Agents
It may increase the hypotensive effect when combined with Antihypertensive Agents
It may increase the hypotensive effect when combined with Antihypertensive Agents
It may increase the hypotensive effect when combined with Antihypertensive Agents
may have an increased hypotensive effect when combined with antipsychotic agents
may have an increased hypotensive effect when combined with antipsychotic agents
may have an increased hypotensive effect when combined with antipsychotic agents
may have an increased hypotensive effect when combined with antipsychotic agents
may have an increased hypotensive effect when combined with antipsychotic agents
may have an increased bradycardic effect when combined with other antihypertensive drugs
may have an increased bradycardic effect when combined with other antihypertensive drugs
may have an increased bradycardic effect when combined with other antihypertensive drugs
may have an increased bradycardic effect when combined with other antihypertensive drugs
may have an increased bradycardic effect when combined with other antihypertensive drugs
They may increase the hypotensive effect when combined with antihypertensive agents
indoramin: they may increase the hypotensive effect when combined with antihypertensive drugs
may reduce the vasoconstriction-inducing action
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may enhance the hyperkalemic effect
may enhance the hyperkalemic effect
may enhance the hyperkalemic effect
may decrease the vasoconstricting effect when combined with alpha1-agonists
bunazosin (Not available in the United States)
may decrease the vasoconstricting effect when combined with alpha1-agonists
may decrease the vasoconstricting effect when combined with alpha1-agonists
may decrease the vasoconstricting effect when combined with alpha1-agonists
may decrease the vasoconstricting effect when combined with alpha1-agonists
may decrease the antihypertensive effect when combined with antihypertensive agents
may decrease the antihypertensive effect when combined with antihypertensive agents
may decrease the antihypertensive effect when combined with antihypertensive agents
may decrease the antihypertensive effect when combined with antihypertensive agents
may decrease the antihypertensive effect when combined with antihypertensive agents
may decrease the vasoconstricting effect when combined with alpha-/beta-agonists
may have an increased bradycardic effect when combined with other hypotensive agents
may have an increased bradycardic effect when combined with other hypotensive agents
may have an increased bradycardic effect when combined with other hypotensive agents
may have an increased bradycardic effect when combined with other hypotensive agents
may have an increased bradycardic effect when combined with other hypotensive agents
may have an increased hypotensive effect when combined with antipsychotic agents
may have an increased hypotensive effect when combined with antipsychotic agents
may have an increased hypertensive effect when combined with androgens
may decrease the vasoconstricting effect when combined with alpha1-agonists
indoramin: they may increase the toxic effect of mu-opioid receptor agonists
indoramin: they may increase the toxic effect of mu-opioid receptor agonists
may increase the hypotensive effect of hypotensive agents
may increase the hypotensive effect of anti-parkinsonism drugs
may increase the hypotensive effect of anti-parkinsonism drugs
may increase the hypotensive effect of anti-parkinsonism drugs
may increase the hypotensive effect of anti-parkinsonism drugs
may increase the hypotensive effect of anti-parkinsonism drugs
indoramin: they may increase the CNS depressant effect of CNS Depressants
indoramin: they may increase the CNS depressant effect of CNS Depressants
indoramin: they may increase the CNS depressant effect of CNS Depressants
indoramin: they may increase the CNS depressant effect of CNS Depressants
indoramin: they may increase the CNS depressant effect of CNS Depressants
may have an increased hypotensive effect when combined with calcium channel blockers
may have an increased hypotensive effect when combined with calcium channel blockers
may have an increased hypotensive effect when combined with calcium channel blockers
may have an increased hypotensive effect when combined with calcium channel blockers
may have an increased hypotensive effect when combined with calcium channel blockers
alpha-1 blocker: they may increase the therapeutic effect of acetylcholine inhibitors
alpha-1 blocker: they may increase the therapeutic effect of acetylcholine inhibitors
The interaction may enhance the hypotensive effects of opioid anti-tussive agents
The interaction may enhance the hypotensive effects of opioid anti-tussive agents
The interaction may enhance the hypotensive effects of opioid anti-tussive agents
it may reduce the effect of antihypertensive agents
Amphetamines may reduce the antihypertensive effect of antihypertensive Agents.
Amphetamines may reduce the antihypertensive effect of antihypertensive Agents.
Amphetamines may reduce the antihypertensive effect of antihypertensive Agents.
Loop Diuretics may increase the hypotensive effect of antihypertensive Agents
Loop Diuretics may increase the hypotensive effect of antihypertensive Agents
Loop Diuretics may increase the hypotensive effect of antihypertensive Agents
alfuzosin may enhance the hypotensive effect of Blood Pressure Lowering Agents
antihypertensive drugs may enhance the hypotensive effect of antipsychotic Agents
antihypertensive drugs may enhance the hypotensive effect of antipsychotic Agents
antihypertensive drugs may enhance the hypotensive effect of antipsychotic Agents
antihypertensive drugs may enhance the hypotensive effect of antipsychotic Agents
antihypertensive drugs may enhance the hypotensive effect of antipsychotic Agents
antihypertensive drugs may enhance the hypotensive effect of antipsychotic Agents
antihypertensive drugs may enhance the hypotensive effect of antipsychotic Agents
antihypertensive drugs may enhance the hypotensive effect of antipsychotic Agents
antihypertensive drugs may enhance the hypotensive effect of antipsychotic Agents
antihypertensive drugs may enhance the hypotensive effect of antipsychotic Agents
antihypertensive drugs may enhance the hypotensive effect of antipsychotic Agents
antihypertensive drugs may enhance the hypotensive effect of antipsychotic Agents
antihypertensive drugs may enhance the hypotensive effect of antipsychotic Agents
antihypertensive drugs may enhance the hypotensive effect of antipsychotic Agents
antihypertensive drugs may enhance the hypotensive effect of antipsychotic Agents
antihypertensive drugs may enhance the hypotensive effect of antipsychotic Agents
antihypertensive drugs may enhance the hypotensive effect of antipsychotic Agents
antihypertensive drugs may enhance the hypotensive effect of antipsychotic Agents
NSAIDs May diminish the anti-hypertensive effect of Beta-Blockers
NSAIDs May diminish the anti-hypertensive effect of Beta-Blockers
NSAIDs May diminish the anti-hypertensive effect of Beta-Blockers
NSAIDs May diminish the anti-hypertensive effect of Beta-Blockers
NSAIDs May diminish the anti-hypertensive effect of Beta-Blockers
may enhance the hypotensive effect of Blood Pressure Lowering Agents
may enhance the hypotensive effect of Blood Pressure Lowering Agents
may enhance the hypotensive effect of Blood Pressure Lowering Agents
may enhance the hypotensive effect of Blood Pressure Lowering Agents
may enhance the hypotensive effect of Blood Pressure Lowering Agents
may enhance the hypotensive effect of Blood Pressure Lowering Agents
Barbiturates may enhance the hypotensive effect of Blood Pressure Lowering Agents
Barbiturates may enhance the hypotensive effect of Blood Pressure Lowering Agents
Barbiturates may enhance the hypotensive effect of Blood Pressure Lowering Agents
Barbiturates may enhance the hypotensive effect of Blood Pressure Lowering Agents
Barbiturates may enhance the hypotensive effect of Blood Pressure Lowering Agents
alpha1-Blockers may reduce the vasoconstricting effect of alpha-/Beta-agonist
may enhance the orthostatic hypotensive effect of alpha1-blockers
may enhance the orthostatic hypotensive effect of alpha1-blockers
may enhance the orthostatic hypotensive effect of alpha1-blockers
may enhance the orthostatic hypotensive effect of alpha1-blockers
may enhance the orthostatic hypotensive effect of alpha1-blockers
may enhance the hypotensive effect of calcium channel blockers
may enhance the hypotensive effect of calcium channel blockers
may enhance the hypotensive effect of calcium channel blockers
may enhance the hypotensive effect of calcium channel blockers
may enhance the hypotensive effect of calcium channel blockers
alpha1-Blockers may enhance the hypotensive effect of phosphodiesterase 5 Inhibitors
alpha1-Blockers may enhance the hypotensive effect of phosphodiesterase 5 Inhibitors
alpha1-Blockers may enhance the hypotensive effect of phosphodiesterase 5 Inhibitors
antihypertensive agents increase the efficacy of antipsychotic agents
it decreases the efficacy of antihypertensive agents
antihypertensive agents include the efficacy of duloxetine
it increases the efficacy of antihypertensive agents
it decreases the efficacy of antihypertensive agents
antihypertensive agents increase the efficacy of nitroprusside
may increase the hypotensive effect
may increase the hypotensive effect
may increase the hypotensive effect
may increase the hypotensive effect
may increase the hypotensive effect
may increase the hypotensive effect
may increase the hypotensive effect
may increase the hypotensive effect
may increase the hypotensive effect
may increase the hypotensive effect
may increase the hypotensive effect
may increase the hypotensive effect
may increase the hypotensive effect
hypotensive agents increase the efficacy of duloxetine
it increases the efficacy of hypotensive agents
it increases the efficacy of hypotensive agents
hypotensive agents increase the blood pressure-lowering effect of nitroprusside
it increases the efficacy of hypotensive agents
may decrease the constriction effects of alpha-1 agonist
may decrease the constriction effects of alpha-1 agonist
hydrocodone/chlorpheniramine/pseudoephedrine
may decrease the vasoconstriction effects of alpha/beta agonists
may increase the bradycardia effect
may increase the hypotensive effect
may increase the hypertensive effect
may increase the hypotensive effect
may increase the hypoglycaemic effect
may enhance the hypotensive effect of antihypertensive agents
may enhance the hypotensive effect of antihypertensive agents
may enhance the hypotensive effect of antihypertensive agents
may reduce the effect of antihypertensive drugs
may reduce the effect of antihypertensive drugs
may reduce the effect of antihypertensive drugs
may reduce the effect of antihypertensive drugs
may reduce the effect of antihypertensive drugs
may enhance the hypotensive effect
may enhance the hypotensive effect
may enhance the hypotensive effect
may enhance the hypotensive effect
may enhance the hypotensive effect
may enhance the hypotensive effect of Alpha1-Blockers
may enhance the hypotensive effect of Alpha1-Blockers
may enhance the hypotensive effect of Alpha1-Blockers
may enhance the hypotensive effect of Alpha1-Blockers
may enhance the hypotensive effect of Alpha1-Blockers
may increase the hypotensive effect of anti-hypertensive agents
acrivastine and pseudoephedrine
may increase the vasoconstrictive effect of alpha/beta agonists
may decrease the hypertensive effect of amphetamines
may increase the hypotensive effect of calcium channel blockers
may increase the hypotensive effect of blood pressure-lowering agents
may increase the hypotensive effect of calcium channel blockers
may increase the hypotensive effect of blood pressure-lowering agents
eprosartan/hydrochlorothiazide
may increase the hypotensive effect of blood pressure-lowering agents
may decrease the antihypertensive effect when combined with antihypertensive agents
may have an increased hypotensive effect when combined with anti-hypertensive agents
may have an increased hypotensive effect when combined with anti-hypertensive agents
may have an increased hypotensive effect when combined with anti-hypertensive agents
may have an increased hypotensive effect when combined with anti-hypertensive agents
may have an increased hypotensive effect when combined with anti-hypertensive agents
may decrease the antihypertensive effect when combined with antihypertensive agents
may decrease the therapeutic effect when combined with antihypertensive agents
relugolix/estradiol/norethindrone
may have an increased hypertensive effect when combined with Androgens
relugolix/estradiol/norethindrone
may have an increased hypertensive effect when combined with Androgens
may have an increased hypertensive effect when combined with Androgens
may have an increased hypertensive effect when combined with Androgens
may have an increased hypertensive effect when combined with Androgens
may have an increased hypotensive effect when combined with duloxetine
may enhance the orthostatic effect of beta blockers
may increase the effect of alpha1-blockers
may increase the effect of alpha1-blockers
may increase the effect of alpha1-blockers
may increase the effect of alpha1-blockers
may increase the effect of alpha1-blockers
may increase the effect of alpha1-blockers
may increase the hypotensive effect of barbiturates
may have an increased hypotensive effect when combined with anti-hypertensive agents
may have an increased hypotensive effect when combined with anti-hypertensive agents
may have an increased hypotensive effect when combined with anti-hypertensive agents
may have an increased hypotensive effect when combined with levodopa-containing products
may have an increased hypotensive effect when combined with anti-hypertensive agents
may have an increased hypotensive effect when combined with nitroprusside
may have an increased hypotensive effect when combined with anti-hypertensive agents
may have an increased hypotensive effect when combined with pholcodine
may increase the hypotensive effect of blood pressure lowering agents
may increase the hypotensive effect of blood pressure-lowering agents
may have an increased hypotensive effect when combined with antihypertensive agents
may have an increased hypotensive effect when combined with antihypertensive agents
may increase the hypotensive effect of Hypotension-Associated Agents
may increase the hypotensive effect of Blood Pressure Lowering Agents
may have an increased hypertensive effect when combined with hypertension agents
may enhance the hypotensive effect
may enhance the hypotensive effect
may enhance the hypotensive effect
may enhance the hypotensive effect
may enhance the hypotensive effect
It may increase the hypotensive effect when combined with Antihypertensive Agents
may increase the hypotensive effect of Hypotension-Associated Agents
may increase the hypotensive effect of Blood Pressure Lowering Agents
may have an increased hypotensive effect when combined with hypotensive agents
may have an increased hypotensive effect when combined with hypotensive agents
may have an increased hypotensive effect when combined with antihypertensive agents
may have an increased therapeutic effect when combined with antihypertensive agents
may decrease the antihypertensive effect when combined with antihypertensive agents
may increase the hypotensive effect of Antipsychotic Agents
may have an increased bradycardic effect when combined with other antihypertensive drugs
may have an increased bradycardic effect when combined with other antihypertensive drugs
may have an increased bradycardic effect when combined with other antihypertensive drugs
may have an increased bradycardic effect when combined with other antihypertensive drugs
may have an increased bradycardic effect when combined with other antihypertensive drugs
may have an increased hypotensive effect when combined with antipsychotic agents
may have an increased hypotensive effect when combined with antipsychotic agents
may have an increased hypotensive effect when combined with antipsychotic agents
may have an increased hypotensive effect when combined with antipsychotic agents
may have an increased hypotensive effect when combined with antipsychotic agents
estrogens esterified/methyltestosterone
may enhance the hypertensive effect of androgens
may decrease the vasoconstricting effect of Alpha-/Beta-Agonists
They may increase the hypotensive effect when combined with antihypertensive agents
It may increase the hypotensive effect when combined with antihypertensive agents
It may increase the hypotensive effect when combined with antihypertensive agents
It may increase the hypotensive effect when combined with antihypertensive agents
It may increase the hypotensive effect when combined with antihypertensive agents
It may increase the hypotensive effect when combined with antihypertensive agents
It may increase the hypotensive effect when combined with antihypertensive agents
antihypertensive drugs may make terazosin's hypotensive effects worse
may have an increased hypotensive effect when combined with antihypertensive agents
blood viscosity-reducing agents: they may increase the hypotensive effect when combined with hypotension-associated agents
blood viscosity-reducing agents: they may increase the hypotensive effect when combined with hypotension-associated agents
may have an increased hypotensive effect when combined with antihypertensive agents
may have an increased bradycardic effect when combined with ivabradine
prazosin: they may increase the hypotensive effect when combined with antihypertensive agents
may increase the hypotensive effect of Phosphodiesterase 5 Inhibitors
may increase the hypotensive effect of Hypotension-Associated Agents
may diminish the effect of antihypertensive activity
may diminish the effect of antihypertensive activity
may diminish the effect of antihypertensive activity
may diminish the effect of antihypertensive activity
may diminish the effect of antihypertensive activity
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may decrease the serum concentration
may decrease the serum concentration
may decrease the serum concentration
may decrease the serum concentration
may decrease the serum concentration
may decrease the serum concentration
may decrease the serum concentration
may decrease the serum concentration
may decrease the serum concentration
may decrease the hypotensive effect of Blood Pressure Lowering Agents
may enhance the QTc-prolonging effect of each other when combined
it increases the toxicity of calcium channel blockers cabergoline
they increase the effect of hypotension of BP-lowering agents
they increase the effect of hypotension of BP-lowering agents
they increase the effect of hypotension of BP-lowering agents
they increase the effect of hypotension of BP-lowering agents
they increase the effect of hypotension of BP-lowering agents
it increases the effect of BP-lowering agents
it decreases the effect of hypotension of blood pressure lowering agents
blood pressure lowering agents increase the effect of hypotension of antipsychotic agents
blood pressure lowering agents increase the effect of hypotension of antipsychotic agents
blood pressure lowering agents increase the effect of hypotension of antipsychotic agents
blood pressure lowering agents increase the effect of hypotension of antipsychotic agents
blood pressure lowering agents increase the effect of hypotension of antipsychotic agents
it increases the effect of hypotension of blood pressure lowering agents
it increases the effect of hypotension of blood pressure lowering agents
it increases the effect of hypotension of blood lowering agents
blood pressure lowering agents increase the effect of hypotension of amifostine
it increases the effect of hypotension of BP-lowering agents
may decrease the vasoconstricting effect when combined with alpha1-agonists
may decrease the vasoconstricting effect when combined with alpha1-agonists
bunazosin (Not available in the United States)
may decrease the vasoconstricting effect when combined with alpha1-agonists
may decrease the vasoconstricting effect when combined with alpha1-agonists
may decrease the vasoconstricting effect when combined with alpha1-agonists
may have an increased therapeutic effect when combined with alpha1-agonists
oxaceprol decreases the effect of anti-hypertensives
may have an increased bradycardic effect when combined with other hypotensive agents
may have an increased bradycardic effect when combined with other hypotensive agents
may have an increased bradycardic effect when combined with other hypotensive agents
may have an increased bradycardic effect when combined with other hypotensive agents
may have an increased bradycardic effect when combined with other hypotensive agents
molsidomine: they may decrease the antihypertensive effect of antihypertensive agents
nicergoline: they may decrease the antihypertensive effect of antihypertensive agents
hydralazine: they may decrease the antihypertensive effect of antihypertensive agents
may increase the hypotensive effect of blood pressure lowering agents
may increase the hypotensive effect of blood pressure lowering agents
may increase the hypotensive effect of antipsychotic agents
may increase the hypotensive effect of antipsychotic agents
may increase the hypotensive effect of alpha1-blockers
may increase the hypotensive effect of alpha1-blockers
may increase the hypotensive effect of alpha1-blockers
may increase the hypotensive effect of alpha1-blockers
may increase the hypotensive effect of alpha1-blockers
quinagolide: they may increase the hypotensive effect of antihypertensive agents
may have an increased orthostatic hypotensive effect when combined with alpha1-blockers
may have an increased orthostatic hypotensive effect when combined with alpha1-blockers
may have an increased orthostatic hypotensive effect when combined with alpha1-blockers
may have an increased hypotensive effect when combined with anti-hypertensive agents
may have an increased orthostatic hypotensive effect when combined with alpha1-blockers
may have an increased orthostatic hypotensive effect when combined with alpha1-blockers
may increase the hypotensive effect of alpha1-blockers
may increase the hypotensive effect of alpha1-blockers
may increase the hypotensive effect of alpha1-blockers
may increase the hypotensive effect of alpha1-blockers
may increase the hypotensive effect of alpha1-blockers
may have an increased orthostatic hypotensive effect when combined with alpha1-blockers
may decrease the vasoconstricting effect when combined with alpha1-agonists
may have an increased hypotensive effect when combined with antihypertensive agents
may have an increased hypotensive effect when combined with antihypertensive agents
may have an increased hypotensive effect when combined with antihypertensive agents
may have an increased hypotensive effect when combined with antipsychotic agents
may have an increased hypotensive effect when combined with antipsychotic agents
may have an increased hypotensive effect when combined with antipsychotic agents
may have an increased hypotensive effect when combined with antipsychotic agents
may have an increased hypotensive effect when combined with antipsychotic agents
an increased risk of hypotension may be seen
moxonidine: it may decrease activities of antihypertensive drugs
ambrisentan: it may decrease activities of antihypertensive drugs
balsalazide: it may decrease activities of antihypertensive drugs
benorilate: it may decrease activities of antihypertensive drugs
benoxaprofen: it may decrease activities of antihypertensive drugs
carvedilol: it may decrease activities of antihypertensive drugs
chlorothiazide: it may decrease activities of antihypertensive drugs
celecoxib: it may decrease activities of antihypertensive drugs
chlorpromazine: it may decrease activities of antihypertensive drugs
amitriptyline: it may decrease activities of antihypertensive drugs
rimiterol: it may decrease activities of antihypertensive drugs
amlodipine: it may decrease activities of antihypertensive drugs
amoxapine: it may decrease activities of antihypertensive drugs
anagrelide: it may decrease activities of antihypertensive drugs
bisoprolol: it may decrease activities of antihypertensive drugs
may increase the hypotensive effect of antipsychotic agents
may increase the hypotensive effect of antipsychotic agents
may increase the hypotensive effect of antipsychotic agents
may increase the hypotensive effect of antipsychotic agents
may increase the hypotensive effect of antipsychotic agents
May diminish the effects of indomethacin by pharmacodynamic antagonism
may increase the hypotensive effect of antipsychotic agents
may increase the hypotensive effect of antipsychotic agents
may increase the hypotensive effect of antipsychotic agents
may increase the hypotensive effect of antipsychotic agents
may increase the hypotensive effect of antipsychotic agents
they modify the response of glucose or insulin when taken with manidipine
it increases the effect of hypotension of blood lowering agents
Frequency defined:
>10%
Retrograde ejaculated
1% to 10%
Orthostatic hypotension
Dizziness
Headache
Insomnia
Weakness
Prostate-specific antigen increased
Diarrhea
Abdominal pain
Nasal congestion
Rhinorrhea
Sinusitis
<1% Postmarketing
Hepatic insufficiency
Hypersensitivity reaction
Pharyngeal edema
Pruritis
Swollen tongue
Syncope
Urticaria
Pregnancy consideration: Not enough studies are available for indoramin, therefore not recommended as initial therapy in pregnant women. Few adverse effects were reported in animal reproductive studies.
Lactation: excretion of indoramin in breast milk is not known.
Pregnancy category:
Patient information leaflet
Generic Name: Indoramin
Pronounced: indoramin
Why do we use indoramin?
Indoramin is used for the treatment of hypertension and benign prostatic hyperplasia.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
